Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates for its ...
Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...
Medical students are taught about some of the rarest diseases, yet do not learn something as important as how to care for trans patients. This needs to change, says intensive care specialist Luke ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.
Hard Truths is now out in cinemas, and here's how Mike Leigh's new movie explores depression in a relatable and original way.